CLB
Get informed when a big investor buys or sells
+ FollowOvervalued by 13.2% based on the discounted cash flow analysis.
| Market cap | $454.72 Million |
|---|---|
| Enterprise Value | $471.29 Million |
| Dividend Yield | $0.04 (0.40%) |
| Earnings per Share | $0.68 |
| Beta | 1.14 |
| Outstanding Shares | 46,878,000 |
| P/E Ratio | 17.7 |
|---|---|
| PEG | -40.22 |
| Price to Sales | 0.9 |
| Price to Book Ratio | 1.98 |
| Enterprise Value to Revenue | 0.91 |
| Enterprise Value to EBIT | 9.87 |
| Enterprise Value to Net Income | 17 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 0.14 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 2.91% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 2.12%▼ 113.49% |
|---|---|
| Total Invested | $9.66M▼ 98.44% |
| Investors Holding | 20▼ 169.00% |
No data
Core Laboratories N.V. is a leading provider of proprietary and patented reservoir description and production enhancement services and products used to optimize petroleum reservoir performance. The Company has over 70 offices in more tha...